Actinium Pharmaceuticals Inc. (ATNM) |
|
0.2509 -0.001 (-0.4%)
|
01-23 16:00 |
|
Open: |
0.25 |
Pre. Close: |
0.2519 |
|
High:
|
0.269255 |
Low:
|
0.25 |
|
Volume:
|
1,671,640 |
Market Cap:
|
41M |
|
|
|
|
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.27 - 0.272 |
0.272 - 0.274 |
|
Low:
|
0.245 - 0.248 |
0.248 - 0.25 |
|
Close:
|
0.247 - 0.25 |
0.25 - 0.252 |
|
Technical analysis |
as of: 2020-01-23 4:36:49 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 0.35 One year: 0.41 |
| Support: |
Support1: 0.24 Support2: 0.20 |
| Resistance: |
Resistance1: 0.30 Resistance2: 0.35 |
| Pivot: |
0.25  |
| Moving Average: |
MA(5): 0.26  MA(20): 0.25
MA(100): 0.23 MA(250): 0.32 |
| MACD: |
MACD(12,26): 0.01 Signal(9): 0.01 |
| Stochastic oscillator: |
%K(14,3): 47.72 %D(3): 58.33 |
| RSI: |
RSI(14): 51.76 |
| 52-week: |
High: 0.71 Low: 0.19 Change(%): -54.5 |
| Average Vol(K): |
3-Month: 297867 10-Days: 529816 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ATNM has closed above bottom band by 43.4%. Bollinger Bands are 23.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 18 Apr 2019 18:47:44 +0000
Mid-Afternoon Market Update: Pier 1 Imports Falls On Downbeat Q4 Results; Mustang Bio Shares Climb
Thu, 18 Apr 2019 16:23:35 +0000
Mid-Day Market Update: Dow Up Over 100 Points; Actinium Pharmaceuticals Shares Plunge
Thu, 18 Apr 2019 06:47:44 +0000
Mid-Afternoon Market Update: Pier 1 Imports Falls On Downbeat Q4 Results; Mustang Bio Shares Climb
Mon, 08 Jan 2018 16:07:00 +0000
Zacks.com featured highlights include: Western Digital, Hecla Mining, Sphere 3D, Actinium Pharmaceuticals and Southern National Bancorp
Fri, 05 Jan 2018 12:48:00 +0000
Beat the Market with Rising P/E Technique
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
